Canrenone
From Wikipedia, the free encyclopedia
Canrenone
|
|
Systematic (IUPAC) name | |
10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione | |
Identifiers | |
CAS number | |
ATC code | C03 |
PubChem | |
Chemical data | |
Formula | C22H28O3 |
Mol. mass | 340.456 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Canrenone is an aldosterone antagonist. The active form, and first metabolite of, Spironolactone.
|